A detailed history of Bank Of America Corp transactions in Cerus Corp stock. As of the latest transaction made, Bank Of America Corp holds 2,362,430 shares of CERS stock, worth $4.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,362,430
Previous 2,080,235 13.57%
Holding current value
$4.3 Million
Previous $3.66 Million 12.26%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.7 - $2.39 $479,731 - $674,446
282,195 Added 13.57%
2,362,430 $4.11 Million
Q2 2024

Aug 14, 2024

SELL
$1.62 - $2.04 $41,612 - $52,401
-25,687 Reduced 1.22%
2,080,235 $3.66 Million
Q1 2024

May 15, 2024

BUY
$1.66 - $2.42 $3.37 Million - $4.91 Million
2,027,252 Added 2576.91%
2,105,922 $3.98 Million
Q4 2023

Feb 14, 2024

BUY
$1.25 - $2.35 $41,525 - $78,067
33,220 Added 73.09%
78,670 $169,000
Q2 2023

Aug 14, 2023

SELL
$1.79 - $2.9 $3.12 Million - $5.06 Million
-1,745,480 Reduced 97.46%
45,450 $111,000
Q1 2023

May 12, 2023

BUY
$2.65 - $3.81 $4.57 Million - $6.58 Million
1,725,927 Added 2655.15%
1,790,930 $5.32 Million
Q4 2022

Feb 10, 2023

SELL
$3.38 - $4.22 $125,617 - $156,836
-37,165 Reduced 36.38%
65,003 $237,000
Q3 2022

Nov 14, 2022

SELL
$3.43 - $5.83 $664,987 - $1.13 Million
-193,874 Reduced 65.49%
102,168 $368,000
Q2 2022

Aug 12, 2022

SELL
$4.41 - $5.69 $79,027 - $101,964
-17,920 Reduced 5.71%
296,042 $1.57 Million
Q1 2022

May 16, 2022

SELL
$4.81 - $6.99 $60,428 - $87,815
-12,563 Reduced 3.85%
313,962 $1.72 Million
Q4 2021

Feb 08, 2022

BUY
$5.97 - $7.93 $357,238 - $474,523
59,839 Added 22.44%
326,525 $2.22 Million
Q3 2021

Nov 15, 2021

SELL
$4.79 - $6.68 $92,245 - $128,643
-19,258 Reduced 6.73%
266,686 $1.62 Million
Q2 2021

Sep 13, 2021

BUY
$5.35 - $6.35 $1.53 Million - $1.82 Million
285,944 New
285,944 $1.69 Million

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $322M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.